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64 The Journal of Thoracic and Cardiohoracoscopic lobectomy, also termed video-assisted thoracoscopic (VATS)
lobectomy, has been demonstrated to be a safe and effective procedure to
treat early-stage non–small cell lung cancer (NSCLC). Advantages of tho-
acoscopic lobectomy, as compared with lobectomy with thoracotomy, include less
ostoperative pain, faster return to full activity, preserved pulmonary function,
horter chest tube duration and length of hospitalization, reduced inflammatory
esponse, and a lower rate of postoperative atrial fibrillation.1,2
Despite these advantages, thoracoscopic lobectomy has not achieved the ex-
ected widespread acceptance seen with other minimally invasive procedures. One
mportant obstacle to the development of this procedure has been confusion regard-
ng the technical aspects of the procedure—the attachment of the term “VATS
obectomy” to a number of procedures with varying degrees of invasiveness and
ncologic effectiveness. Thoracoscopic lobectomy should be defined as a com-
letely thoracoscopic procedure performed with a limited number of ports (one or
wo) and an access incision (approximately 5 cm in length) for individual vessel and
ronchial dissection and ligation (stapling), as well as specimen removal.3 Impor-
antly, rib spreading with retractors is not used. “Video-assisted” procedures that
nclude thoracotomy with rib spreading or rib resection do not qualify, because the
dvantages of the minimally invasive approach are attributed to the avoidance of
his practice.
Another obstacle has been the uncertainty regarding oncologic effectiveness of
he thoracoscopic approach. Although there are no prospective, randomized studies
omparing survival after the open and thoracoscopic approaches, there is also no
vidence to support a difference if the procedure is performed as described.3 Large
eries describing extensive experience with thoracoscopic lobectomy report stage-
pecific survival that is at least equivalent to historical series.2 Furthermore, con-
erns regarding the effectiveness of the thoracoscopic mediastinal lymph node
issection are unfounded. This has been demonstrated as well.1-4
The study by Shigemura and colleagues4 analyzes surgical outcomes for clinical
tage IA NSCLC (tumor size  2 cm only), comparing completely thoracoscopic,
ATS-assisted, and open techniques. The premise of the study is that there is a lack
f studies with “long-term follow-up” in comparing VATS with alternative tech-
iques. This is not entirely true, as several centers have extensive experience and
easonable follow-up.1,2,5 Furthermore, the premise that there is controversy regard-
ng the 3 procedures studied is misleading. The advantages associated with com-
letely thoracoscopic lobectomy are attributable to the avoidance of rib spreading,
nd the use of VATS “assistance” during minithoracotomy does not confer these
dvantages.
This study is difficult to interpret because several of the primary outcomes differ
rom what would be found in other studies. One example is length of hospitalization:
n this study, hospital stay is shorter in the thoracoscopic group than the other 2
roups, a finding consistent with the literature. However, the result is 4 times longer
han in other studies (12 days vs 3 days).1,2 Thus, the conclusion that the completely
horacoscopic technique is associated with a shorter length of stay than the alter-
atives is not clinically relevant. In addition, the operative times and survival are
uch longer than in other studies, and these deviations go unexplained.
Of note, this study is the first to document statistically that there is no difference
n the ability to perform a complete mediastinal lymph node dissection by enumer-
ting the lymph nodes removed. The thoracoscopic approach included an equivalent
vascular Surgery ● September 2006
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Lumber of lymph nodes (23 9) as compared with the open
pproach (25  7; P  not significant).4 Other questions
egarding this study arise. It is unclear why the authors
hose 2 cm as the cutoff for this study of clinical stage IA
ung cancer. It is also unclear how patients were chosen for
of the 3 operations. Is there any selection bias? The study
f 145 patients is not powered to show anything but a huge
ifference in survival, which would not be expected. Thus,
urvival is not a meaningful end point for comparison in this
tudy. In summary, this study confirms that thoracoscopic
obectomy is a safe and effective approach for the resection of
arly-stage NSCLC and that mediastinal lymph node dissec-
ion is not compromised by the thoracoscopic approach.
With increasing experience, the indications for thoraco-
copic lobectomy have been expanded. Thoracoscopic lo-
ectomy has been found to be applicable to larger stage I
nd II tumors, central pulmonary metastases,2,5 granuloma-
ous lung disease, and to patients after induction chemother-
py.5 Thoracic surgery training programs may soon be
equired to demonstrate faculty competency in thoraco-
copic lobectomy to improve resident experience. Although
pecific training for this procedure has been successful in
edicated courses and preceptorships for surgeons in prac-
ice, providing this training during residency would be ideal.
Confirmation of the oncologic effectiveness of thoraco-
copic lobectomy would be best demonstrated by a large,
rospective, randomized series, which will not be forthcom-
ng. A phase III trial comparing thoracoscopic to conven-
ional lobectomy would require accrual of more than 800
The Journal of Thoracicatients, which is prohibitive. Furthermore, there is not
ufficient equipoise among most thoracoscopic surgeons to
ermit randomization. However, a prospective registry trial
as been proposed by the Cancer and Leukemia Group B
CALGB) and will likely be approved and funded. The
ALGB trial will accept accrual of lobectomy patients,
sing either the completely thoracoscopic approach or tho-
acotomy, comparing survival and quality of life. Although
ot randomized, the registry design will allow comparisons
f important variables in appropriately matched patients.
inally, the role of thoracoscopic lobectomy is currently
eing explored in patients receiving adjuvant chemother-
py. It is possible that the thoracoscopic approach will
mprove patient compliance with chemotherapy and ulti-
ately improve survival.
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